Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 3 recruiting now early-phase tilt small index

Chronic Inflammation: early-phase trial registry

3 of 5 indexed Chronic Inflammation trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #3,391 of 28,707 conditions by registered trial count.

5 US clinical trials · 3 currently recruiting · #3,391 of 28,707 conditions by registered trial count

Chronic Inflammation: 5 US clinical trials tracked, 3 recruiting.

Chronic Inflammation is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Minneapolis Veterans Affairs Medical Center, running 1 of these trials.

Enrollment posture brief

Registry condition chronic-inflammation

OPEN 3 | RECR 60% | LATE 0 | EARLY 2 | RANK #3391 | SPON 1

Nearest open-share peer: Acute Kidney Injury (AKI) (60% recruiting · 5 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Chronic Inflammation (this)60%
Open-enrollment share among volume-matched conditions near Chronic Inflammation

Chronic Inflammation lists 3 open slots (60% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Chronic Inflammation on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Chronic Inflammation is recruiting above its size-band peers.

    3 of 5 indexed trials (60%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Chronic Inflammation research.

    Minneapolis Veterans Affairs Medical Center accounts for 1 of 5 trials (20%). 5 distinct sponsors appear on at least one study for this condition label.

  3. Most Chronic Inflammation trials plan to enrol fewer than 100 people.

    Median target enrolment is 40 among the 5 trials that report a genuine target (sentinel values excluded). 5 of those (100%) plan for fewer than 100 participants.

  4. Chronic Inflammation splits between interventional and observational designs.

    3 interventional and 2 observational studies make up this index (60% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 22

Phase Distribution

PhaseTrial count
Phase 2 2

Named interventions

Most-linked intervention names on Chronic Inflammation records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

passive heat stress Other
1 trials
Modified-Release Prednisone Drug
1 trials
Bariatric surgery Procedure
1 trials
Control Other
1 trials
Tirzepatide Drug
1 trials
Placebo Drug
1 trials

US sites by state

Facility locations filed on Chronic Inflammation trials. A trial with sites in several states counts in each.

Utah 1 trials
Texas 1 trials
Minnesota 1 trials
Hawaii 1 trials
Arizona 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Chronic Inflammation page

5 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Chronic Inflammation condition card totals 5 registered trials; most-linked intervention passive heat stress; top US site state Utah. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.